Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiaceutics Share News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 97.50
Bid: 97.00
Ask: 98.00
Change: -1.50 (-1.51%)
Spread: 1.00 (1.031%)
Open: 99.50
High: 99.00
Low: 98.00
Prev. Close: 99.50
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Sondrel wins USD23 million contract

Tue, 27th Feb 2024 14:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Signs an exploration agreement for the acquisition of its proprietary database of lithium targets in Texas. Smackover Resources LLC, a wholly owned subsidiary of Lonestar Lithium Inc, has purchased the proprietary database with regional modelling and data compilation across eastern Texas from Cloudbreak. The terms include: 2.0 million shares in Lonestar; USD25,000 each time a Qualifying Transaction property is generated from the database; and 0.5% Royalty produced lithium on each Qualifying Transaction property. The areement is for three years. Interim Chief Executive Andrew Male says: "This Exploration Agreement is a good example of the type of transactions Cloudbreak has completed in the past and will continue to do with a sector of its asset base. It took considerable time and effort to compile this database and being able to sell this on to Lonestar demonstrates the possible valuation accretion by doing this type of business."

----------

United Oil & Gas PLC - Oil and gas company, focused on Egypt, the UK and Jamaica - Raises GBP1.0 million through oversubscribed placing of 457.5 million shares and 42.5 shares by way of a subscription. A total of 500.0 million shares will be issued through the fundraising, 76% of the company's issued share capital. Funds will be used to progress work in Jamaica and for administration costs.

----------

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Expands its data supply network, which it says will significantly increase the number of labs through which Diaceutics is sourcing data in Europe and will broaden the company's European data coverage. This data will accelerate the rollout of the DxRx Signal product in key EU markets of Germany, France, Italy, Spain and the UK. Jordan Clark, chief data officer of Diaceutics, comments: "This data will further endorse our position as a leading provider of data to biotech and pharma companies as they commercialize their products, find and deliver therapies to patients across multiple geographies."

----------

Crossword Cybersecurity PLC - London-based cybersecurity solutions provider - Launches Trillion HarVista. Says the Trillion HarVista tool allows enterprise security teams to search conversations on the dark web in a clean and sanitised environment. It "enables security teams, for the first time, to be able to identify the threats developing both from hacker discussions and shared compromised credential data all from a single interface, without the risk of searches on hostile websites being linked to your organisation."

----------

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Receives a first purchase order under the master services agreement with an unnamed "leading diagnostics company." The first purchase order, valued at around GBP60,000, has been received for an initial project to generate antibodies specifically for the client's use in diagnostic products. It is anticipated that further purchase orders will follow for additional and recurring projects. CEO Adrian Kinkaid says: "Reaching this agreement with a world class diagnostics provider positively reinforces the value to the wider commercial world of Fusion Antibodies' technologies and capabilities. In this case it is the generation of antibodies in diagnostics products. We look forward to establishing a long-term relationship with our new partner and providing them with assistance to generate better antibodies which are more manufacturable and can be rapidly deployed in clinical diagnostic products for the benefit patient well-being across the globe."

----------

Sondrel Holdings PLC - Reading, England-based semiconductor design services firm - Wins new design and supply contract for a next generation video processing chip with a total estimated value of USD23 million across the design, qualification and projected production life of the product. "The complex chip is to be used for high performance professional video streaming solutions. The company has entered into the master agreement with the customer and design work has commenced whilst the parties finalise negotiations to the exhibits to the agreement," it says. The initial contract value is for over USD9 million for the duration of the design and qualification phases and the work will be fully funded by the customer. CEO Graham Curren says: "This is a substantial design and supply contract for Sondrel and a demonstration of the group's ability to provide the most complex engineering expertise required for these next generation technologies. We're delighted to partner with one of the leading manufacturers in the high growth video streaming market, where the constant innovation and focus on efficiency is driving demand for complex chips like Sondrel's." Also reports that it has received four new orders in 2024 year to date for its design consulting services, engaging with two existing customers and two new customers. These contracts will generate a combined revenue of USD900,000 in the current financial year.

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
9 Apr 2024 12:34

Diaceutics appoints new VP of marketing

(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.

Read more
2 Apr 2024 19:02

TRADING UPDATES: Roadside shares suspended; Adnams looks for funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
21 Mar 2024 13:58

Diaceutics upgrades diagnositc commercialisation platform, DXRX

(Alliance News) - Diaceutics PLC on Thursday said it has launched a "significant upgrade" to its DXRX platform.

Read more
14 Feb 2024 13:52

IN BRIEF: Diaceutics announces new marketing partnership with KPMG

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Announces strategic alliance with KPMG LLC, which provides tax, audit and advisory services and commercialisation solutions for life sciences and healthcare companies. Diaceutics says the partnership will facilitate joint marketing of commercialisation solutions to life science customers for commercialisation of precision medicines.

Read more
30 Jan 2024 11:16

Diaceutics maintains "momentum" for year ahead on revenue rise in 2023

(Alliance News) - Diaceutics PLC on Tuesday highlighted the extent of market opportunities for its product, after seeing annual revenue rise despite tough macroeconomic conditions.

Read more
26 Sep 2023 11:37

Diaceutics revenue grows but loss widens, CEO Keeling to step down

(Alliance News) - Diaceutics PLC on Tuesday reported strong revenue growth in its first half despite a widened loss, as well as strong demand from new customers despite a cautious atmosphere in the pharmaceutical sector.

Read more
29 Aug 2023 13:16

IN BRIEF: Diaceutics launches daily alerts for DXRX platform

Diaceutics PLC - Belfast-based testing laboratories company - Launches daily alerts update for its DXRX Signal platform, which it says will allow clients to identify patients who previously weren't receiving "the most appropriate treatment" due to lack of timely data. Adds that it has identified over 46,000 patients this year for its biopharma clients.

Read more
25 Jul 2023 12:12

Diaceutics interim revenue jumps as order book grows to GBP24 million

(Alliance News) - Diaceutics PLC on Tuesday reaffirmed its full year outlook, after delivering revenue growth of 32% in the first six months of the year.

Read more
6 Jun 2023 13:47

Director dealings: BAT, Diaceutics execs make investments

(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.

Read more
5 Jun 2023 11:09

IN BRIEF: Diaceutics shares surge on contract win with top US firm

Diaceutics PLC - Belfast-based testing laboratories company - Wins a three-year enterprise contract with an unnamed "top 10 global pharmaceutical company" based in the US. Says the contract will bring in USD10.1 million in revenue over its term, with options to "significantly" increase its scope and value. Revenue will be recognised monthly, with immediate effect. Says revenue will be recognised on a monthly basis. It will deliver a range of subscription data services via its DXRX platform.

Read more
26 Apr 2023 20:28

DIRECTOR DEALINGS: Energean shareholder sells GBP6.6 million in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
17 Apr 2023 14:16

IN BRIEF: Diaceutics achieves increase in annual revenue and profit

Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP19.5 million for 2022, up 40% from GBP13.9 million in 2021. Pretax profit is GBP564,000, up from GBP462,000, as operating profit increases to GBP575,000 from GBP550,000 a year earlier. Administrative expenses increase to GBP16.3 million from GBP11.9 million. Earnings before interest, tax, depreciation and amortisation amounts to GBP3.6 million, up from GBP2.3 million. Order book stands at GBP16.9 million at year-end, compared to GBP1.8 million a year earlier.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
13 Mar 2023 11:10

Diaceutics shares resume trading after HSBC buys SVB UK

(Sharecast News) - Pharmaceutical technology and service provider Diaceutics announced at mid-morning on Monday that the temporary suspension of its shares on AIM would be lifted.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.